RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Return 18.15%
This Quarter Return
+13.86%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$5.94B
AUM Growth
-$52.2M
Cap. Flow
-$268M
Cap. Flow %
-4.51%
Top 10 Hldgs %
66.2%
Holding
90
New
5
Increased
10
Reduced
9
Closed
27

Top Buys

1
CDTX icon
Cidara Therapeutics
CDTX
$111M
2
TSHA icon
Taysha Gene Therapies
TSHA
$29.3M
3
RNA icon
Avidity Biosciences
RNA
$27.4M
4
HNGE
Hinge Health, Inc.
HNGE
$15.5M
5
TYRA icon
Tyra Biosciences
TYRA
$14.9M

Top Sells

1
APGE icon
Apogee Therapeutics
APGE
$58.6M
2
ZLAB icon
Zai Lab
ZLAB
$46.8M
3
DAWN icon
Day One Biopharmaceuticals
DAWN
$45.6M
4
URGN icon
UroGen Pharma
URGN
$35.5M
5
RYTM icon
Rhythm Pharmaceuticals
RYTM
$33.1M

Sector Composition

1 Healthcare 99.82%
2 Financials 0.13%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
BIOA
76
BioAge Labs, Inc. Common Stock
BIOA
$171M
– –
-1,052,494
Closed -$3.96M
CBLL
77
CeriBell, Inc. Common Stock
CBLL
$433M
– –
-824,582
Closed -$15.8M
INSM icon
78
Insmed
INSM
$30.7B
– –
-200,000
Closed -$15.3M
ITOS
79
DELISTED
iTeos Therapeutics
ITOS
– –
-3,649,057
Closed -$21.8M
KURA icon
80
Kura Oncology
KURA
$713M
– –
-4,004,610
Closed -$26.4M
LXEO icon
81
Lexeo Therapeutics
LXEO
$271M
– –
-546,554
Closed -$1.9M
NRIX icon
82
Nurix Therapeutics
NRIX
$758M
– –
-1,333,333
Closed -$15.8M
SCLX icon
83
Scilex Holding
SCLX
$159M
– –
-29,606
Closed -$258K
SERA icon
84
Sera Prognostics
SERA
$127M
– –
-3,032,808
Closed -$11.2M
STRO icon
85
Sutro Biopharma
STRO
$89.9M
– –
-4,434,637
Closed -$2.89M
URGN icon
86
UroGen Pharma
URGN
$873M
– –
-3,206,271
Closed -$35.5M
XNCR icon
87
Xencor
XNCR
$610M
– –
-575,000
Closed -$6.12M
ZLAB icon
88
Zai Lab
ZLAB
$3.42B
– –
-1,295,040
Closed -$46.8M
ZURA icon
89
Zura Bio
ZURA
$143M
– –
-3,217,503
Closed -$4.15M
BOLD
90
Boundless Bio
BOLD
$25.7M
– –
-2,180,631
Closed -$3.29M
1 2 3
4